颅外弥漫性大B细胞淋巴瘤患者的代谢性脑网络模式重塑
本研究为回顾性研究,旨在建立弥漫性大B细胞淋巴瘤相关代谢脑网络模式(DLBCLRP),并分析其与分期及疗效评估指标的相关性。DLBCLRP表现为双侧小脑、脑干、丘脑、纹状体、海马、杏仁核、海马旁回及右侧颞中回代谢增高,双侧枕叶、顶叶、前扣带回、中扣带皮质及内侧额回代谢减低。DLBCLRP基线表达在完全代谢缓解、部分代谢缓解和进展性代谢病组间有显著差异(P<0.01),且与IPI、lg(TMTV)等肿瘤负荷指标相关。
要点
- DLBCLRP特征为小脑、脑干、丘脑、海马等代谢增高,枕叶、顶叶、扣带回及内侧额回代谢减低。
- DLBCLRP基线表达在CMR、PMR和PMD组间差异有统计学意义(P<0.01)。
- DLBCLRP表达与IPI(rs=0.306,P<0.05)和lg(TMTV)(r=0.298,P<0.05)正相关。
核心结论
- 所提出的DLBCLRP为进一步研究DLBCL本身和/或治疗相关的脑功能障碍奠定基础。
- DLBCLRP表达与淋巴瘤肿瘤负荷相关,提示其可能作为预后生物标志物。
研究设计与样本
- 回顾性研究,旨在建立弥漫性大B细胞淋巴瘤相关代谢脑网络模式(DLBCLRP),并分析其与分期及疗效评估指标的相关性。
主要发现
- DLBCLRP表现为双侧小脑、脑干、丘脑、纹状体、海马、杏仁核、海马旁回及右侧颞中回代谢活性增高。
- DLBCLRP表现为双侧枕叶、顶叶、前扣带回、中扣带皮质及内侧额回代谢活性减低。
- DLBCLRP基线表达在完全代谢缓解(CMR)、部分代谢缓解(PMR)和进展性代谢病(PMD)组间差异有统计学意义(P<0.01)。
- DLBCLRP表达与IPI呈正相关(rs=0.306,P<0.05),与lg(TMTV)呈正相关(r=0.298,P<0.05)。
- DLBCLRP表达与lg(TLG)呈正相关趋势(r=0.233,P=0.064)。
关键数值与推荐
- DLBCLRP基线表达在CMR、PMR和PMD组间差异有统计学意义(P<0.01)。
- DLBCLRP表达与IPI正相关(rs=0.306,P<0.05)。
- DLBCLRP表达与lg(TMTV)正相关(r=0.298,P<0.05)。
- DLBCLRP表达与lg(TLG)呈正相关趋势(r=0.233,P=0.064)。
- DLBCLRP表达与Ann Arbor分期或肿瘤SUVmax无显著相关性(P>0.05),但治疗后DLBCLRP表达下降与Ann Arbor分期(rs=0.284,P<0.05)和IPI(rs=0.297,P<0.05)呈显著正相关。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Owing to the advances in diagnosis and therapy, survival or remission rates for lymphoma have improved prominently. Apart from the lymphoma- and chemotherapy-related somatic symptom burden, increasing attention has been drawn to the health-related quality of life. The application of 18F-fluorodeoxyglucose positron emission tomography-computed tomography (18F-FDG PET/CT) has been routinely recommended for the staging and response assessment of FDG-avid lymphoma. However, up till now, only a few researches have investigated the brain metabolic impairments in patients with pre-treatment lymphoma. The determination of the lymphoma-related metabolic brain pattern would facilitate exploring the tailored therapeutic regimen to alleviate not only the physiological, but also the psychological symptoms. In this retrospective study, we aimed to establish the diffuse large B-cell lymphoma-related pattern (DLBCLRP) of metabolic brain network and investigate the correlations between DLBCLRP and several indexes of the staging and response assessment. RESULTS: The established DLBCLRP was characterized by the increased metabolic activity in bilateral cerebellum, brainstem, thalamus, striatum, hippocampus, amygdala, parahippocampal gyrus and right middle temporal gyrus and by the decreased metabolic activity in bilateral occipital lobe, parietal lobe, anterior cingulate gyrus, midcingulate cortex and medial frontal gyrus. Significant difference in the baseline expression of DLBCLRP was found among complete metabolic response (CMR), partial metabolic response (PMR) and progressive metabolic disease (PMD) groups (P < 0.01). DLBCLRP expressions were also significantly or tended to be positively correlated with international prognostic index (IPI) (rs = 0.306, P < 0.05), lg(total metabolic tumor volume, TMTV) (r = 0.298, P < 0.05) and lg(total lesion glycolysis, TLG) (r = 0.233, P = 0.064). Though no significant correlation of DLBCLRP expression was found with Ann Arbor staging or tumor SUVmax (P > 0.05), the post-treatment declines of DLBCLRP expression were significantly positively correlated with Ann Arbor staging (rs = 0.284, P < 0.05) and IPI (rs = 0.297, P < 0.05). CONCLUSIONS: The proposed DLBCLRP would lay the foundation for further investigating the cerebral dysfunction related to DLBCL itself and/or treatments. Besides, the expression of DLBCLRP was associated with the tumor burden of lymphoma, implying a potential biomarker for prognosis.
引用
- Liu J, Tang M, Zhu D, et al. The remodeling of metabolic brain pattern in patients with extracranial diffuse large B-cell lymphoma. EJNMMI Res. 2023. PMID: 37902852. doi:10.1186/s13550-023-01046-6
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。